Is HCYT or JEPQ a better dividend investment in 2026?

HCYT currently yields 201.01% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: HCYT offers higher current income.

What is the dividend yield difference between HCYT and JEPQ?

HCYT has a forward dividend yield of 201.01% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 189.91 percentage points.

Home › Compare › HCYT vs JEPQ

HCYT vs JEPQ: Dividend Comparison 2026

HCYT yields 201.01% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HCYT wins by $122.84M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HCYT

● Live price

201.01%

Share price

$1.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$122.88M

Annual income

$62,103,539.90

Full HCYT calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — HCYT vs JEPQ

📍 HCYT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HCYT	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HCYT + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HCYT pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HCYT

Annual income on $10K today (after 15% tax)

$17,085.43/yr

After 10yr DRIP, annual income (after tax)

$52,788,008.92/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, HCYT beats the other by $52,786,179.21/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HCYT + JEPQ for your $10,000?

HCYT: 50%JEPQ: 50%

100% JEPQ50/50100% HCYT

Portfolio after 10yr

$61.46M

Annual income

$31,052,846.24/yr

Blended yield

50.52%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HCYT buys

JEPQ buys

No recent congressional trades found for HCYT or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHCYTJEPQ

Forward yield	201.01% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$122.88M ✓	$44.8K
Annual income after 10y	$62,103,539.90 ✓	$2,152.59
Total dividends collected	$115.84M ✓	$16.3K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: HCYT vs JEPQ ($10,000, DRIP)

Year	HCYT Portfolio	HCYT Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$30,801	$20,100.50	$11,930	$1,110.39	+$18.9K → HCYT
2	$90,817	$57,860.33	$14,133	$1,224.34	+$76.7K → HCYT
3	$256,617	$159,443.16	$16,632	$1,340.46	+$240.0K → HCYT
4	$695,638	$421,057.46	$19,454	$1,457.97	+$676.2K → HCYT
5	$1,811,064	$1,066,731.28	$22,626	$1,576.08	+$1.79M → HCYT
6	$4,533,343	$2,595,504.46	$26,175	$1,694.09	+$4.51M → HCYT
7	$10,922,551	$6,071,874.75	$30,133	$1,811.32	+$10.89M → HCYT
8	$25,359,524	$13,672,394.20	$34,531	$1,927.17	+$25.32M → HCYT
9	$56,801,975	$29,667,284.47	$39,403	$2,041.08	+$56.76M → HCYT
10	$122,881,654	$62,103,539.90	$44,787	$2,152.59	+$122.84M → HCYT

HCYT vs JEPQ: Complete Analysis 2026

HCYT — Stock

H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.

Full HCYT Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this HCYT vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HCYT vs SCHD HCYT vs JEPI HCYT vs O HCYT vs KO HCYT vs MAIN HCYT vs XYLD HCYT vs QYLD HCYT vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.